PI12052 (R)-1,2,3,4-Tetrahydronaphthoic acid (CAS No.: 23357-47-3)

(R)-1,2,3,4-Tetrahydronaphthoic acid Description

This compound, with the molecular formula C11H12O2 and CAS Number 23357-47-3, serves as an essential intermediate in pharmaceutical synthesis. Its defined stereochemistry supports accurate chiral construction in complex drug pathways. The powder form enables precise measurement and integration into reaction protocols, ensuring reproducible synthesis outcomes. Detailed analytical data underpin its application in specialised synthesis routes.

(R)-1,2,3,4-Tetrahydronaphthoic acid Applications

1.         Pharmaceutical Manufacturing
- Used as an intermediate in asymmetric synthesis to construct active pharmaceutical ingredients by leveraging its controlled stereochemistry, which addresses challenges in enantiomer separation.
- Applied in small-molecule production to improve reaction reproducibility through accurate dosing enabled by its powder form.

2.         Chemical Research and Development
- Employed in laboratory synthesis experiments to validate reaction mechanisms by taking advantage of its well-documented purity and stereochemical properties.
- Utilised in process optimisation studies to refine reaction parameters and enhance yield consistency based on its controlled production profile.

(R)-1,2,3,4-Tetrahydronaphthoic acid Packing

The compound is packaged in sealed polyethylene bottles to reduce moisture ingress and contamination. Each bottle is enclosed in a secondary anti-static holder to protect against mechanical damage during transit. Storage in a cool, dry, and dark environment is advised. Custom packaging options, such as moisture-resistant pouches and clear labelling, are available for specialised handling requirements.

Additional Information

Pharmaceutical intermediates like (R)-1,2,3,4-Tetrahydronaphthoic acid play a critical role in multi-step organic synthesis. Their precise chemical composition and defined stereochemistry are essential for constructing complex molecules in drug development. Understanding the reaction pathways and inherent material properties facilitates efficient integration into synthetic processes.

Advancements in analytical techniques have significantly improved the control over synthesis parameters. Detailed characterisation using methods such as HPLC, NMR, and mass spectrometry provides insights into the compound's purity and structural integrity, reinforcing its application in both research and commercial pharmaceutical manufacturing.